Updates in Endometriosis Management

Kristin Blackledge, Michael Saad-Naguib, Peter G. McGovern
In: Topics in Obstetrics & Gynecology · 2024 · vol. 44(16) , pp. 1–5 · doi:10.1097/01.pgo.0001069572.69135.a0 · W4402954897
OA: closed CC0
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This review discusses recent advancements in understanding the pathophysiology and novel therapeutic approaches for endometriosis management.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-07, 2026-07-16 · read from full text ⓘ

This paper presents an educational update on endometriosis management, authored by clinicians in obstetrics and gynecology affiliated with Rutgers New Jersey Medical School. It is structured as a continuing medical education (CME) and continuing nursing professional development (NCPD) activity, describing accreditation details and credit parameters rather than reporting a specific experimental study with population-level methods or results. The text provided does not include substantive findings, outcomes, or limitations beyond the administrative educational context. This paper is centrally about endometriosis—an “Updates in Endometriosis Management” educational overview focused on management topics for the endometriosis condition.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 2,292 characters · extracted from oa-doi-fallback · click to expand
Updates in Endometriosis Management Blackledge, Kristin MD, MA; Saad-Naguib, Michael MD; McGovern, Peter G. MD Dr. Blackledge is a Resident and Dr. Saad-Naguib is a Fellow, Department of Obstetrics and Gynecology, Rutgers New Jersey Medical School, MSB E-506, 185 South Orange Ave, Newark, NJ 07101; E-mail: [email protected]; and Dr. McGovern is Professor, Department of Obstetrics and Gynecology, Rutgers New Jersey Medical School, Newark, New Jersey, and University Reproductive Associates, Hasbrouck Heights, New Jersey. All authors, faculty, and staff have no relevant financial relationships with any ineligible organizations regarding this educational activity. CME Accreditation Lippincott Continuing Medical Education Institute, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Lippincott Continuing Medical Education Institute, Inc., designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. To earn CME credit, you must read the CME article and complete the quiz and evaluation on the enclosed answer form, answering at least 70% of the quiz questions correctly. Please visit https://cme.lww.com/browse/sources/153. This CME activity expires at 5 pm EST on November 14, 2026. NCPD Accreditation Lippincott Professional Development is accredited as a provider of nursing continuing professional development (NCPD) by the American Nurses Credentialing Center's Commission on Accreditation. Lippincott Professional Development will award 2.0 contact hours for this NCPD activity. This activity has been assigned 0.5 pharmacology credits. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 2.0 contact hours. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia, Georgia, West Virginia, New Mexico, South Carolina, and Florida, CE Broker #50-1223. Your certificate is valid in all states. Instructions for earning ANCC contact hours are included on page 6 of the newsletter. This NCPD activity expires on September 4, 2026.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (51)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-10-09T06:36:44.367587+00:00
License: CC0 · commercial use OK